Ampersand Ventures

Skip to content

Archives

2007

November 28, 2007

RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital

October 3, 2007

CRI Worldwide Partners with Private Equity Investors to Advance Growth Strategy

August 28, 2007

Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer

August 6, 2007

ChanTest Receives Expansion Capital from Ampersand Ventures; Builds World’s Largest Catalog of Ion Channel-Expressing Cell Lines for Use in Drug Discovery and Development

June 18, 2007

Cequent Pharmaceuticals Completes $9 Million Series a Financing With Equity Investment from Novartis Option Fund

May 31, 2007

Endeca Reports Record Q1 Revenue, Plans to Create Hundreds of New Jobs

April 16, 2007

Cambridge BioScience appointed as European Distributor for ChanTest

April 2, 2007

Ortho Organizers, Inc. Introduces New Product Line - Ancor Pro Orthodontic Anchorage System

March 20, 2007

Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs

January 4, 2007

Victory Pharma, Inc. Signs NAPRELAN® Agreement; US Field Sales Force to Expand

January 3, 2007

Victory Pharma, Inc. Announces Investigational New Drug MGX-006 Approved by the FDA

2006

November 28, 2006

Magellan Biosciences Expands Presence in Hospital-Based Laboratory Market with Acquisition of TREK Diagnostic Systems

November 20, 2006

Talecris Biotherapeutics Completes Acquisition of Plasma Collection Centers

2005

August 5, 2005

Ortho Organizers, Inc. Announces Change in Ownership

July 11, 2005

Assay Designs Acquires Stressgen Bioreagents

May 9, 2005

Ampersand Invests in Assay Designs

May 2, 2005

Ampersand invests in Stressgen Bioreagents Corporation

April 1, 2005

Announcing the Launch of Talecris Biotherapeutics: Combining a Proud History of Patient Care with a Bold New Vision

2004

December 13, 2004

Bayer To Divest its Plasma Products Business To US Investors Cerberus and Ampersand

December 1, 2004

Ampersand Ventures Invests in IBT Reference Laboratory

October 19, 2004

Magellan Biosciences, Inc. Formed Through Combination of ESA and Dynex

May 20, 2004

Ampersand Ventures Acquires Life Science Tools Provider ESA, Inc.

April 27, 2004

Proficiency Raises $12 Million Investment Round

Contact Us

Interested in working with Ampersand? Contact us.